Skip to content
TheBias Brief

The GuardianSig. 7OpinionPoliticsForeignTrade

Canada is seeking new global neighbours – no wonder, as Trump rolls out stupidities at scale | David Moscrop

The article argues Canada is right to seek closer ties with the European Union as the Trump administration engages in absurd, bullying, and destabilizing behavior. It criticizes Trump's trade tactics and rhetoric as juvenile and destructive while urging coordinated resistance and a move beyond US hegemony.

New York PostSig. 8NewsAIForeignTrade

US pitches China on AI notification deal ahead of UN General Asssembly

The US proposed an AI notification exchange system with China during talks ahead of the UN General Assembly, modeled on the Cold War Washington-Moscow hotline. The two sides did not extend their trade truce, which expires in November, and Trump is set to host Xi Jinping for a state visit later in the week.

Neutral

The HillSig. 8OpinionForeignTradeDefense

Beware Beijing bearing gifts as Xi visits America’s dealmaker-in-chief

An opinion piece warns that Xi Jinping's Washington visit comes amid China's deep commercial penetration of U.S. infrastructure and key industries, arguing trade must be viewed through national security and enforcement lenses. It credits the Trump administration with accelerating a shift from decades of permissive trade policy to stricter scrutiny, while acknowledging the two economies remain intertwined.

Right 3.3

Washington ExaminerSig. 6OpinionHealthEconomyTrade

Trump’s drug price plan targets foreign freeloaders — but shoots American innovators

An op-ed argues that the Trump administration’s GLOBE and GUARD Medicare pilot programs, meant to stop foreign free-riding on U.S. drug prices, would instead penalize small and mid-size American biotech firms. Because those firms often out-license foreign marketing rights, the piece says they cannot control foreign pricing and would bear costs they cannot recover, potentially reducing innovation and patient access. It urges the administration to confront foreign governments directly rather than penalize U.S. innovators.

Right 3.9

Fox NewsSig. 5OpinionHealthEconomyTrade

If Trump wants to lower drug prices, his obvious free-riding targets are outside the US

This opinion piece argues that Trump's new drug pricing agreements are commendable but insufficient because the root cause of high U.S. drug prices is foreign governments free-riding on American pharmaceutical innovation. It urges the administration to target foreign price controls and rebate policies so other wealthy nations pay more for medicines.

Right 3.6

Wall Street JournalSig. 6NewsTradeEconomy

How Harley-Davidson, an American Icon, Became a Tariff Punching Bag

Harley-Davidson has repeatedly been targeted by retaliatory tariffs from foreign governments, including a new 50% import duty from Canada, due to its symbolic status as an American manufacturer. The article outlines past and current tariff actions against the company.

Neutral

BBC NewsSig. 8NewsAIForeignTrade

US and China discuss AI safety plan ahead of Trump-Xi summit

US Treasury Secretary Scott Bessent said Washington and Beijing discussed creating a notification mechanism for AI incidents that could affect national security, following talks with Chinese Vice Premier He Lifeng. The talks come ahead of a planned Trump-Xi summit and amid a tariff truce due to expire in November. The article also notes recent warnings about AI risks and Trump's dismissal of calls to slow AI development.

Neutral